Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

March 23, 2026 13:55 ET | Source: Bitstarz

Bitcoin Casino No Deposit Bonus 2026: BitStarz Adds 50 Free Spins with Code BIGWIN50 Real Money Bonus & Fast Payouts

New York City, NY, March 23, 2026 (GLOBE NEWSWIRE) -- As demand for Bitcoin casino no deposit bonuses continues to rise in 2026, players are becoming more selective about which offers are...
March 23, 2026 12:45 ET | Source: VINCI

Combined Ordinary and Extraordinary General Meeting on Tuesday 14 April 2025 - Information concerning the availability of preparatory documents

A French public limited company (société anonyme) with share capital of €1,455,643,262.50Registered office: 1973, boulevard de la Défense, F-92000 NanterreRegistration number 552 037 806 RCS...
March 23, 2026 10:35 ET | Source: Ilkka Oyj

Kutsu Ilkka Oyj:n varsinaiseen yhtiökokoukseen

Ilkka Oyj Pörssitiedote 23.3.2026, klo 16.35 KUTSU ILKKA OYJ:N VARSINAISEEN YHTIÖKOKOUKSEENIlkka Oyj:n osakkeenomistajat kutsutaan varsinaiseen yhtiökokoukseen, joka pidetään torstaina...
March 23, 2026 10:15 ET | Source: Ilkka Oyj

Ilkka Oyj:n palkitsemis- ja nimitysvaliokunnan ehdotukset yhtiökokoukselle ja hallintoneuvoston lausunto osakkeenomistajien ehdotuksesta yhtiökokoukselle

Ilkka Oyj Pörssitiedote 23.3.2026, klo 16.15ILKKA OYJ:N PALKITSEMIS- JA NIMITYSVALIOKUNNAN EHDOTUKSET YHTIÖKOKOUKSELLE JA HALLINTONEUVOSTON LAUSUNTO OSAKKEENOMISTAJIEN EHDOTUKSESTA...
March 23, 2026 09:15 ET | Source: RedCloud Holdings plc

RedCloud CEO Declares the Decline of Systems of Record as It Validates R.A.I.D. AI Engine Built for Modern Global Trade

London, UK, March 23, 2026 (GLOBE NEWSWIRE) -- RedCloud Holdings plc (NASDAQ: RCT) ("RedCloud" or the "Company"), the technology company building AI infrastructure for global trade today declared...
March 23, 2026 08:30 ET | Source: Vaxcyte, Inc.

Vaxcyte Completes Enrollment of OPUS-1 and OPUS-2 Phase 3 Trials Evaluating VAX-31 for the Prevention of Invasive Pneumococcal Disease and Pneumonia in Adults

OPUS-1 Phase 3 Study Designed to Establish a New Standard for Adult Pneumococcal Conjugate Vaccines (PCVs) Through Head-to-Head Safety, Tolerability and Immunogenicity Comparisons of VAX-31 with...
March 23, 2026 08:00 ET | Source: Amphista Therapeutics

Amphista Therapeutics announces three presentations at the American Association for Cancer Research Annual Meeting on its next-generation Targeted Glue™ degrader programs

Cambridge, UK, 23rd March 2026 – Amphista Therapeutics (“the Company” or “Amphista”), a leader in the discovery and development of non-cereblon/non-VHL Targeted Glue™ degraders, today announces three...
March 23, 2026 07:30 ET | Source: FuelCell Energy, Inc.

FuelCell Energy Scales Up for Data Centers with Packaged 12.5 MW Utility‑Grade Power Block Solution and Manufacturing Expansion Plans

DANBURY, Conn., March 23, 2026 (GLOBE NEWSWIRE) -- FuelCell Energy, Inc. (NASDAQ: FCEL) is taking significant steps toward meeting the speed of delivery and surging demand of data centers for...
March 23, 2026 07:17 ET | Source: VALNEVA

Pfizer et Valneva annoncent que le candidat vaccin contre la maladie de Lyme démontre une forte efficacité dans l’essai de Phase 3 VALOR

Le candidat vaccin PF-07307405 (LB6V) a démontré une efficacité de plus de 70 % dans la prévention de la maladie de Lyme chez les personnes âgées de cinq ans et plus.Le candidat vaccin a été bien...
March 23, 2026 07:00 ET | Source: Algernon Health Inc.

Algernon to Open the First Brain Dedicated PET Scanning Clinic in the U.S. at the HCA Florida University Medical Office Building

VANCOUVER, British Columbia, March 23, 2026 (GLOBE NEWSWIRE) -- Algernon Health Inc. (the “Company” or “Algernon”) (CSE: AGN) (FRANKFURT: AGW0) (OTCQB: AGNPF), is pleased to announce that it will be...